Negative and positive regulation of HIF-1: a complex network - PubMed (original) (raw)
Review
Negative and positive regulation of HIF-1: a complex network
Julia I Bárdos et al. Biochim Biophys Acta. 2005.
Abstract
Hypoxia inducible factor-1 (HIF-1) is as a key transcriptional mediator of the hypoxic response in eukaryotic cells, regulating the expression of a myriad of genes involved in oxygen transport, glucose uptake and glycolysis and angiogenesis. Deregulation of HIF-1 activity occurs in many human cancers, usually at the level of the HIF-1alpha subunit. HIF-1 is regulated by a variety of mechanisms including transcription, translation post-translational modification, protein-protein interaction and degradation. Our understanding of the key signalling pathways that regulate HIF-1 has significantly progressed in recent years and has highlighted the potential for targeting the HIF-1 pathway as a basis for the development of new cancer therapies.
Similar articles
- The HIF pathway: implications for patterns of gene expression in cancer.
Wykoff CC, Pugh CW, Harris AL, Maxwell PH, Ratcliffe PJ. Wykoff CC, et al. Novartis Found Symp. 2001;240:212-25; discussion 225-31. doi: 10.1002/0470868716.ch15. Novartis Found Symp. 2001. PMID: 11727931 Review. - Oxygen(es) and the hypoxia-inducible factor-1.
Wenger RH, Gassmann M. Wenger RH, et al. Biol Chem. 1997 Jul;378(7):609-16. Biol Chem. 1997. PMID: 9278140 Review. - Cardiac expressions of HIF-1 alpha and HLF/EPAS, two basic loop helix/PAS domain transcription factors involved in adaptative responses to hypoxic stresses.
Ladoux A, Frelin C. Ladoux A, et al. Biochem Biophys Res Commun. 1997 Nov 26;240(3):552-6. doi: 10.1006/bbrc.1997.7708. Biochem Biophys Res Commun. 1997. PMID: 9398602 - Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas.
Wiesener MS, Münchenhagen PM, Berger I, Morgan NV, Roigas J, Schwiertz A, Jürgensen JS, Gruber G, Maxwell PH, Löning SA, Frei U, Maher ER, Gröne HJ, Eckardt KU. Wiesener MS, et al. Cancer Res. 2001 Jul 1;61(13):5215-22. Cancer Res. 2001. PMID: 11431362 - Generation of bidirectional hypoxia/HIF-responsive expression vectors to target gene expression to hypoxic cells.
Post DE, Van Meir EG. Post DE, et al. Gene Ther. 2001 Dec;8(23):1801-7. doi: 10.1038/sj.gt.3301605. Gene Ther. 2001. PMID: 11803400
Cited by
- Hypoxia and metabolic properties of hematopoietic stem cells.
Zhang CC, Sadek HA. Zhang CC, et al. Antioxid Redox Signal. 2014 Apr 20;20(12):1891-901. doi: 10.1089/ars.2012.5019. Epub 2013 Jun 21. Antioxid Redox Signal. 2014. PMID: 23621582 Free PMC article. Review. - HPV and Other Microbiota; Who's Good and Who's Bad: Effects of the Microbial Environment on the Development of Cervical Cancer-A Non-Systematic Review.
Läsche M, Urban H, Gallwas J, Gründker C. Läsche M, et al. Cells. 2021 Mar 23;10(3):714. doi: 10.3390/cells10030714. Cells. 2021. PMID: 33807087 Free PMC article. Review. - Targeted cancer gene therapy using a hypoxia inducible factor dependent oncolytic adenovirus armed with interleukin-4.
Post DE, Sandberg EM, Kyle MM, Devi NS, Brat DJ, Xu Z, Tighiouart M, Van Meir EG. Post DE, et al. Cancer Res. 2007 Jul 15;67(14):6872-81. doi: 10.1158/0008-5472.CAN-06-3244. Cancer Res. 2007. PMID: 17638898 Free PMC article. - Hypoxia signaling pathway: A central mediator in endocrine tumors.
Watts D, Jaykar MT, Bechmann N, Wielockx B. Watts D, et al. Front Endocrinol (Lausanne). 2023 Jan 9;13:1103075. doi: 10.3389/fendo.2022.1103075. eCollection 2022. Front Endocrinol (Lausanne). 2023. PMID: 36699028 Free PMC article. Review. - Associations between metabolic syndrome and gynecologic cancer.
Lee DY, Lee TS. Lee DY, et al. Obstet Gynecol Sci. 2020 May;63(3):215-224. doi: 10.5468/ogs.2020.63.3.215. Epub 2020 Mar 31. Obstet Gynecol Sci. 2020. PMID: 32489965 Free PMC article. Review.